NCT06724653View on ClinicalTrials.gov

Tapering Heart Failure Medication in Patients with Heart Failure with Recovered Ejection Fraction; Open Label Prospective Random Trial

NANot yet recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

December 6, 2025

Primary Completion Date

November 26, 2026

Study Completion Date

November 26, 2027

Conditions

Heart FailureEjection FractionRecovery of Function

Interventions

DRUG

RAS blocker tapering group

RAS blocker tapering out

DRUG

Beta blocker tapering out

Beta blocker tapering out group

All Listed Sponsors

lead

Chungnam National University Hospital

OTHER

NCT06724653 - Tapering Heart Failure Medication in Patients with Heart Failure with Recovered Ejection Fraction; Open Label Prospective Random Trial | Biotech Hunter | Biotech Hunter